Molecular profiling of ctDNA in pancreatic cancer: Opportunities and challenges for clinical application

Pancreatic ductal adenocarcinoma (PDAC) is predicted to become the second leading cause of cancer-related mortality within the next decade, with limited effective treatment options and a dismal long-term prognosis for patients. Genomic profiling has not yet manifested clinical benefits for diagnosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Sivapalan, L., Kocher, H.M., Ross-Adams, H., Chelala, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Karger Publishers 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994018/
https://www.ncbi.nlm.nih.gov/pubmed/33451936
http://dx.doi.org/10.1016/j.pan.2020.12.017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994018/
https://www.ncbi.nlm.nih.gov/pubmed/33451936
http://dx.doi.org/10.1016/j.pan.2020.12.017

Ejemplares similares